Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 24.66
Key Takeaways
Risk factor
Very high price volatility
Data is available to registered users only
Data is available to registered users only
Profitability factor
Very weak growth
Data is available to registered users only
Data is available to registered users only
About
ANG Lifesciences India Ltd. engages in the manufacture and marketing of finished pharmaceutical formulations in a form of sterile dry powder for injection vials. Its products include sterile dry powder vials for antibiotics, anti ulcerant, glucocorticoid, and anti-inflammatory, anti-malaria, and anesthetics. The company was founded by Rajesh Gupta on June 14, 2006 and is headquartered...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is overvalued on EV/EBITDA.
Data is available to registered users only
Buy
Sell